Coffee sold at Dollar General recalled over potential glass presence
A popular coffee product sold in all but two US states is being recalled after the company received consumer reports that glass shards were found in it. Dollar General announced its voluntary recall of Clover Valley Instant Coffee on Monday 'due to the potential presence of glass.'
The product was sold and distributed in Dollar General stores in every state except Hawaii and Alaska. The company was alerted to the issue after a customer notified Dollar General employees of glass in the product.
In its recall notice, the FDA stated: 'Ingesting glass fragments may cause injury to the consumer, and these injuries may include damage to teeth, laceration of the mouth and throat, or perforation of the intestine.' The units were sold and distributed between July 9 and 21, 2025.
No injuries have been reported to date. The three recalled lots include 8-Ounce Clover Valley Instant Coffee with a package UPC of 876941004069. The products have the following lot numbers: Lot: L-5163; Lot: L-5164; and Lot: L-5165. Best by dates include December 13, 2026 and December 14, 2026.
Customers can find the lot number and best by date information around the neck of the coffee product's bottle. Dollar General is investigating the source of the glass contamination but it is not currently known how glass may have ended up in the product.
Small pieces of glass will likely pass through the body without causing symptoms, but larger pieces or those with sharp edges can cause serious harm. Glass can cut the mouth, throat, esophagus, stomach and intestines. This can lead to blood in the stool, chest and abdominal pain, and if the cut is severe enough, you may develop fever, chills, bloating and a swollen abdomen.
If glass cuts the intestines, a person could experience a gastrointestinal perforation, which is a serious medical emergency and requires immediate surgery. It can lead to the contents of the intestines leaking into the abdominal cavity. This can cause organ damage and sepsis, a deadly infection.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
21 minutes ago
- Daily Mail
Boston boy, 4, suffers terrifying HIV scare moments after mistaking city's drug addicts for ZOMBIES
A four-year-old boy suffered a terrifying HIV scare after he was pricked in the foot by a dirty hypodermic needle that had been discarded by the 'zombie' drug addicts who have taken over the streets of Boston. The youngster was jabbed by the needle while attending a birthday party in a South Boston park near his family home on July 11. He ran out of the play area without any shoes on and screamed as a needle stuck out of the big toe on his left foot, his mother Caroline Flynn recalled. 'I was freaking out. I was scared,' Flynn told The Boston Herald, noting how 'there was leftover blood in that needle'. He was rushed to the emergency room at nearby Boston Medical Center where he underwent extensive blood testing, got an x-ray, and was prescribed multiple anti-HIV preventative medicines, which he reportedly 'wasn't able to tolerate'. After a month of panic, Flynn finally got some 'relief' on Wednesday when doctors informed her that her son's 'blood tests came back negative' for HIV and hepatitis. Flynn, who is urging Massachusetts lawmakers to address the crippling opioid crisis, has now heartbreakingly shared how her son mistook the drug addicts that stagger through Boston as 'zombies'. 'We were sitting down at McDonald's and he looked out the window and said, "Look Mom, zombies!",' Flynn told the newspaper. Drug addicts stumble through Boston's city parks and streets, and are known to openly shoot up in public. Drug users are pictured smoking and shooting up at the intersection of Atkinson and Southampton Street in the South Boston neighborhood She says her son watched as addicts stumbled around public streets, claiming that some were even openly shooting up. He witnessed visibly intoxicated people pushing rusty wheelchairs and old shopping carts around. Others rode around on city-operated rental bicycles, she claimed. Flynn has called on legislators to urgently take action, telling the newspaper how 'something needs to be done' to combat the drugs epidemic. The mother even suggested that anyone caught shooting up in public be arrested and forced to undergo addiction treatment. Boston's raging drug problem has been in the spotlight after residents lashed out at Democrat Mayor Michelle Wu, blaming her policies that allegedly enable drug use. Locals claim Wu's controversial decision to hand out free crack pipe syringes and other paraphernalia to addicts in 2022 has helped fuel the problems. While her administration pitched the move as 'harm reduction,' critics have countered that all she's done is increase the permissiveness of public drug use in Boston. Massachusetts state Sen. Nick Collins is among those pushing for a crackdown on the city's open-air drug markets and has branded the Flynn family's case as 'collateral damage caused by the ongoing crisis at Mass and Cass'. The intersection of Massachusetts Avenue and Melnea Cass Boulevard, known as 'Mass and Cass,' is notorious for open-air drug usage. Wu has tried to clear out the crime-ridden area, dubbed 'Methadone Mile', by trying to take down tent encampments. But instead of isolating the drug crisis, it has amplified and spread - further plaguing the historic city. Flynn's son stepped on a needle in park near the corner of Columbia Road and Mercer Street, less than two miles away from the so-called Methadone Mile. 'Nobody should have to worry about stepping on a needle in a public park,' Collins told the Herald, adding that we 'owe it to the boy' to intervene. The senator called for a reform of the city's public health policies, as well as protocols on civil interventions and discharge policies. Residents from across Boston have complained that the Mass and Cass crackdown has led to 'out of control' spillover into their neighborhoods. The streets of once-pristine communities, including ritzy Beacon Hill where the median housing price is $2.8million, have been left littered with dangerous needles. A clean-up crew supported by the Newmarket Business Improvement District has estimated they pick up about 1,000 needles a day across Boston. Wu's office, in a statement issued to the newspaper Thursday morning, reiterated that outdoor drug use is 'illegal and unacceptable'. The mayor's office said they are using 'active and continuous police enforcement' in drug-stricken areas and working to 'transition individuals into recovery programs'. The city is said to be focused on needle pickup and has expanded working hours for its needle collection teams. Boston has also ended its outdoor and weekend syringe exchange. 'No family should have to worry about their children's safety playing outside,' the statement added.
The Guardian
21 minutes ago
- The Guardian
Ozempic didn't work for me. I was furious
I'm 46 years old and I have been on a diet since I was 11. For as long as I can remember, eating has given me comfort. As a kid, I lied to my friends' parents so I could eat a second dinner at their house. I've never wanted just one cookie – I'd eat 12 and only stop when I felt physically ill, and sometimes not even then. In nearly every photo of me as a teenager I'm wincing, sucking in my stomach, trying to pose. I never really enjoyed the taste of these foods, nor was I happy with myself after eating them. They came with a side of guilt: you don't deserve this. This relentless food noise trapped me in a cycle of wanting to eat, then shaming myself for doing it. I spent inordinate energy hating my too tall, too big body. I always felt simultaneously like not enough and too much. Now, GLP-1 drugs like Ozempic, Wegovy and Mounjaro are being hyped as an easy fix to obesity. Their manufacturers have experienced significant revenue growth credited to the drugs' popularity; for instance, Eli Lilly recently announced 38% yearly growth, credited in part to sales of Zepbound and Mounjaro. Media headlines tout the changes in weight and appetite for those who take them. But what if the 'miracle' doesn't work for you? Being diagnosed with diabetes at age 27 threw me deeper into a shame spiral. At the time, my doctor clinically defined me as obese. That, along with the prognosis of a deficient pancreas, felt like punishment for decades of failing to control my overeating. Given my family history of diabetes – my grandpa had it – the doctor diagnosed me as type 2 and recommended dramatic lifestyle adjustments, including carb counting and daily exercise. She also did an A1C test, which measures average blood sugar levels for three months. A non-diabetic's result would be under 5.7%. Mine was 7.7%. This diagnosis felt like being sentenced to lifelong obsession. Food already controlled me, and now it had even more power. Over the next five years, I worked with a nutritionist and psychotherapist. I trained for a 200-mile relay race with friends. I did Weight Watchers, went to Overeaters Anonymous, worked the 12-step program, and used apps like Noom and My Fitness Pal. I lost 50lb. Still, I remained overweight according to the BMI chart, and my A1C didn't budge, which confounded my primary care doctor. She referred me to an endocrinologist who specialized in metabolic health. Six months later, when my appointment finally arrived, my A1C had shot up to 9.1%. That should not have happened while I shed pounds. She declared I was misdiagnosed: type 2 diabetics' bodies make insulin, which helps regulate blood sugar, but don't use it effectively. But I was actually type 1, an autoimmune condition where the body stops producing insulin. I would be dependent on insulin injections from that point forward. Living with diabetes was taxing. I had to order a continuous glucose monitor (CGM), pen needles, insulin vials and other items – but via a specialty supplier rather than a standard pharmacy, for insurance purposes. I had to procure pre-authorization forms for medication and attend required half-day training sessions every time I wanted to try a different insulin pump or when my insurance changed. But in 2018, after five years of effort, my A1C settled in at 5.9% – a happy result for me and my doctor. But to get to a weight my doctor would approve, I still had to lose 30lb. She started me on a new drug called Ozempic. Like most people at that point, I'd never heard of it. She said it was only technically approved for type 2 patients – but some who were overweight with type 1, like me, were taking it to help with weight loss. Over the next four years, my doctor and I gradually increased my Ozempic dosage and eventually were pleased with the results: when I woke in the morning my fasting blood sugar reading was finally within the recommended range of 80-120 on my CGM. I was able to reduce my regular insulin usage. But my weight didn't change. I continued my healthier eating habits and exercised regularly with cycling, yoga and running. Still, the scale didn't move. In 2022, when Ozempic was becoming a household name, I suddenly had two problems. First, my doctor confirmed I was already on the highest available dose, so taking more wouldn't help me lose weight. Second, because the drugs were now approved for general weight loss, I might have trouble filling my prescription. A global shortage followed, and I went four months without, eventually switching to Mounjaro because it was available. My already-thin friends started taking GLP-1s, and I couldn't avoid chatter about the 'skinny shot'. 'I'm not even hungry! I don't even think about food!' they'd say. But I didn't experience this quieting of the voices in my head telling me I was hungry all the time, and I wondered why. I was furious. As my friends celebrated their new bodies, I wondered, again, what was wrong with mine. My diabetes was under control, but I was also existing at the margins of a miracle. An estimated 15% of all GLP-1 users are so-called 'non-responders' to the weight loss effect, according to Atlanta-based physician Dr Cristina Del Toro Badessa. Lucas Veritas, a GLP-1 user from Montreal and author of The GLP-1 Effect newsletter, highlighted clinical trials showing that approximately 13% of people taking semaglutide (the active ingredient in Ozempic and Wegovy) and about 9% of those taking tirzepatide (found in Mounjaro and Zepbound) did not lose more than 5% of their body weight. 'The meds are highly effective for a majority of patients but there is still a percentage who don't lose a clinically significant percentage of body weight. Everyone's physiology is a little different,' said Veronica Johnson MD, an obesity medicine specialist in Chicago. Recent research has identified a gene that may help predict who will successfully lose weight with GLP-1 medications. Sign up to Well Actually Practical advice, expert insights and answers to your questions about how to live a good life after newsletter promotion Additionally, according to a recent study comparing GLP-1 medications to bariatric surgery, 'real world' cohorts lost less weight than what drug companies reported in their trials: about 5% of their body weight, compared with the 15% reported for semaglutide and the 20–25% for tirzepatide in pharma-funded studies. Nicoletta LaMarca-Sacco, 56, a former Ozempic user in New York, also didn't lose weight after a year of use. 'I've always been a squishy mom and will continue to be,' she said. 'It just didn't work for me.' She expected the drug would quiet more of the internal chatter telling her she needed to snack. 'It did help, but only to a small degree,' she said. 'When we consider these drugs, they need to be combined with other markers of good health like diet, exercise, even stress management,' said Dr Raj Dasgupta, an ABIM Quadruple board-certified physician in Los Angeles. He said his patients sometimes had unrealistic expectations about how quickly and dramatically they will drop extra pounds. He explained that for someone who is overweight, shedding even a small amount of weight can improve heart and kidney function, adding: 'The bar has been set too high for weight loss.' 'What's dangerous,' Badessa said, 'is the dominant societal narrative that these are 'magic shots' for weight loss.' Veritas agreed: 'Expectations are sky-high. People see all the before/after photos and expect an easy ride.' 'It feels similar to any other time the diet industry has thrown marketing momentum behind one particular 'fix',' Virginia Sole-Smith, author of Fat Talk, told me about the current hype. 'There's excitement that we've found a 'silver bullet', then it silences any other narratives and experiences about it.' I had definitely been looking for an elixir to rid me of body mass. Then I discovered that diabetes itself might be the reason I wasn't losing weight. Andrew Koutnik, a metabolic research scientist, said that GLP-1s typically lead to significant weight loss for people with obesity (15-25% of their body weight). However, people with diabetes generally lost less weight, proportionally: for type 2, an average of 8-11%; for type 1, about 8-12%. 'While we don't know why this is occurring, prior data suggests the drug's metabolic effects may be tied to how well the body manages glucose,' Koutnik said. GLP-1s are designed to coax the body into making and using insulin more efficiently, he explained. But for someone with type 1 diabetes, meaning their pancreas cannot make insulin, that's like installing a turbocharger on a car with no engine – there's nothing to boost. That said, he clarified, these drugs aren't entirely useless for people with type 1. GLP-1s slow digestion and suppress appetite, which can lead to fewer snacks and less carb-heavy meals. That might nudge blood sugar in the right direction, but it's more of a side-effect. 'The actual impact on blood sugar control is minimal: less than a 1% drop in A1C,' Koutnik explained. The psychological fallout of being a non-responder can be devastating. It was more fodder for my destructive inner dialogue: Why won't my body just comply? Alyson Curtis, a therapist based in New York, works with patients who feel isolated as they see others losing weight and don't have the same result. I told her how unfair it felt and she agreed the loss of agency can be a lot to process. 'I hear the 'thin fantasy' constantly from patients – it's a dream to fit into societal norms,' Curtis added, 'but what they're really saying is they want to be accepted, cherished, adored.' She helps patients reframe success to focus on healthy outcomes beyond weight loss – like how the Health at Every Size (HAES) movement centers on overall wellbeing. Still, these drugs are here to stay. Johnson pointed to recent innovations like CagriSema, a compound drug bringing together an amylin agonist and a GLP-1. In trials, CagriSema helped reduce blood sugar spikes after meals and can also contribute to weight loss. 'The hormone called amylin is normally released by the same cells that make insulin – which type 1 diabetics lack,' Koutnik said. He added that amylin helps slow digestion and also lowers levels of glucagon, which could help better manage blood sugar. Society seems to have rewritten ideas about health, worth and willpower through the lens of these astonishing drugs. I figured I could, too. I've tried to quiet the inner voice that's shaming me into thinking I'm a failure for not losing more weight. Forging self-acceptance from deep frustration, I am realizing there is nothing inherently 'wrong' with my body – I am simply among those for whom the current medications produce a partial benefit. Learning that I'm not alone has helped curb my body shame. I am grateful that GLP-1s have helped me with blood sugar control, minimizing my risk of complications from diabetes. 'When we focus on the miracle weight loss narrative, we ignore their real value in helping people with diabetes, adding to the discourse of body shaming, which is never health-promoting,' said Sole-Smith. I've been trying to shift my focus from weight loss to improving my relationship with food. For me, that's learning to eat with more intention and maybe even a little joy. Hopefully, I can come to appreciate my right to the occasional indulgence without self-recrimination. And on my next birthday, I want to celebrate with the most delicious symbol of self-acceptance: a guilt-free piece of cake.
Daily Mail
an hour ago
- Daily Mail
California city named world's most relaxing...but it's beaches are strewn with SEWAGE from nearby southern border
San Diego has been named the world's most relaxing city - but the tranquility of its golden beaches are under threat from sewage seeping in from the southern border. The California city was ranked first as the 'top city to unwind' based on metrics including spa access, air quality, sunshine hours, happiness and natural spaces. International eSIM provider Holafly gave the coastal metropolis a 'relaxation score' of 68.7 out of 100, followed by Singapore with 66.8 and Vienna, Austria with 63.5. This owed in large part to San Diego having 'the sunniest climate' among the cities listed, with an average of eight hours and nine minutes of bright sunlight per day. The picturesque city's balmy climate draws flocks of residents and tourists to South Mission and Central Beach each year - but the tides have turned in recent months. Analysis of the beaches on both sides of the southern border over the past two years have detected alarming levels of fecal matter in the water stretching 50 miles north of the US-Mexico coastal border, scientists have warned. One Coast Project and Permanent Forum of Binational Waters researchers have said fecal bacteria in the sea exceeded health standards almost every day of the year. The groups have collected water samples since 1999 along 65 miles of western coastline from Carlsbad, California, to Baja California in Mexico. Extremely high levels of enterococci bacteria, which can cause serious infections, were detected in Southern California beaches over the spring in particular. Researchers said they found an average of 15,000 units of the bacterium pre 100 milliliters of water, which is almost 100 times the legal limit in the US and Mexico. Enterococci comes from fecal contamination, and it can cause gnarly gastrointestinal, skin, urinary tract and even heart infections. The bacteria type has been found much more frequently in San Diego waters since 2020, after a sharp rise in the contamination on the Mexican side in 2018. Director of One Coast Project Rosario Sanchez told Fox News there are very different testing protocols on each side of the border. 'In the U.S. side, there's more standardized procedures in terms of how often testing is done, basically daily, but on the Mexico side it can be just once a month if that,' she said. Sanchez said that coastal water quality is way off meeting basic health standards for more than 325 days per year across the coastline. 'This has impacts on both sides on both sides of the border, we're not talking just water quality, but we're talking about health,' she said. The contamination in San Diego is also compounded by toxic sewage spills from the Tijuana River Valley on the south side of the border city. Californians living in the Imperial Beach area have complained about respiratory problems and other complications that they believe are linked to the waste in the river. According to the San Diego Coastkeeper, the 'failing sewage infrastructure in Mexico' and 'negligent operation of the South Bay Plant by the US government' are to blame for the pollution and smell. On the US side, crews have placed riprap - large rocks - in the river in an attempt to stop the foul smell of sewage from plaguing the valley. In Mexico, environment groups are working to replace a section of an ageing sewage pipeline with a newer one made of concrete. However, the only way to rebuild the pipeline with minimal pollution was to allow sewage waste to run through the river during the construction. The International Boundary and Water Commission, a federal government agency monitoring the waterways between Mexico and the US, announced on April 9 that the team in Mexico would be working around the clock to fix the pipeline. The US side of the IBWC said Mexico had informed them that the decision to dump five million gallons of wastewater a day into the river was a 'difficult decision,' but there were no other alternatives to fixing the sewage problem. The IBWC said that even though the sewage dump was 'bad news,' the decision was the best way to prevent wastewater from polluting the Tijuana River long-term.
